On 31 December 2019, Chinese authorities reported the increase in incidence of severe pneumonia in Wuhan city, Hubei province of China. One week later, on January 7th, they confirmed that they had identified a new coronavirus, which is a family of microRNA respiratory viruses including the common cold, and viruses such as Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). This new virus was temporarily named “2019-nCoV”. Wuhan city is a major international transport hub. This report to World Health Organization (WHO), raised global public health concern because this is the third coronavirus –associated acute respiratory illness outbreak.
Organization WH. Novel Coronavirus (2019-nCoV) Situation report-9, 29 January 2020. Geneva, Switzerland. 2020.
Organization WH. Surveillance case definitions for human infection with novel coronavirus ( nCoV): interim guidance v1, January 2020. World Health Organization, 2020.
Organization WH. Novel Coronavirus (2019-nCoV) advice for the public: interim guidance. World Health Organization.
Organization WH. Infection prevention and control during health care when novel coronavirus ( nCoV) infection is suspected: interim guidance, 25 January 2020. World Health Organization, 2020.
Organization WH. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, 28 January 2020. World Health Organization, 2020.